NINDS Peripheral Neuropathy Information Page
Skip secondary menu
Table of Contents (click to jump to sections)
Is there any treatment?
What is the prognosis?
What research is being done?
Clinical Trials
Organizations
Related NINDS Publications and Information
Publicaciones en Español
Additional resources from MEDLINEplus
What is Peripheral Neuropathy?
Peripheral neuropathy describes damage to the peripheral nervous system, which transmits information from the brain and spinal cord to every other part of the body.
More than 100 types of peripheral neuropathy have been identified, each with its own characteristic set of symptoms, pattern of development, and prognosis. Impaired function and symptoms depend on the type of nerves -- motor, sensory, or autonomic -- that are damaged. Some people may experience temporary numbness, tingling, and pricking sensations, sensitivity to touch, or muscle weakness. Others may suffer more extreme symptoms, including burning pain (especially at night), muscle wasting, paralysis, or organ or gland dysfunction. Peripheral neuropathy may be either inherited or acquired. Causes of acquired peripheral neuropathy include physical injury (trauma) to a nerve, tumors, toxins, autoimmune responses, nutritional deficiencies, alcoholism, and vascular and metabolic disorders. Acquired peripheral neuropathies are caused by systemic disease, trauma from external agents, or infections or autoimmune disorders affecting nerve tissue. Inherited forms of peripheral neuropathy are caused by inborn mistakes in the genetic code or by new genetic mutations.
Is there any treatment?
No medical treatments exist that can cure inherited peripheral neuropathy. However, there are therapies for many other forms.
In general, adopting healthy habits -- such as maintaining optimal weight, avoiding exposure to toxins, following a physician-supervised
exercise program, eating a balanced diet, correcting vitamin deficiencies, and limiting or avoiding alcohol consumption --
can reduce the physical and emotional effects of peripheral neuropathy. Systemic diseases frequently require more complex
treatments.
What is the prognosis?
In acute neuropathies, such as Guillain-Barré syndrome, symptoms appear suddenly, progress rapidly, and resolve slowly as
damaged nerves heal. In chronic forms, symptoms begin subtly and progress slowly. Some people may have periods of relief followed
by relapse. Others may reach a plateau stage where symptoms stay the same for many months or years. Some chronic neuropathies
worsen over time, but very few forms prove fatal unless complicated by other diseases. Occasionally the neuropathy is a symptom
of another disorder.
What research is being done?
The National Institute of Neurological Disorders and Stroke (NINDS) and other institutes of the National Institutes of Health
(NIH) conduct research related to peripheral neuropathies in laboratories at the NIH and also support additional research
through grants to major medical institutions across the country. Current research projects funded by the NINDS involve investigations
of genetic factors associated with hereditary neuropathies, studies of biological mechanisms involved in diabetes-associated
neuropathies, and investigations exploring how the immune system contributes to peripheral nerve damage. Neuropathic pain
is a primary target of NINDS-sponsored studies aimed at developing more effective therapies for symptoms of peripheral neuropathy.
Some scientists hope to identify substances that will block the brain chemicals that generate pain signals, while others are
investigating the pathways by which pain signals reach the brain.
NIH Patient Recruitment for Peripheral Neuropathy Clinical Trials
| American Chronic Pain Association (ACPA) P.O. Box 850 Rocklin, CA 95677-0850 ACPA@pacbell.net http://www.theacpa.org Tel: 916-632-0922 800-533-3231 Fax: 916-652-8190 |
Neuropathy Association 60 East 42nd Street Suite 942 New York, NY 10165-0999 info@neuropathy.org http://www.neuropathy.org Tel: 212-692-0662 Fax: 212-692-0668 |
| National Foundation for the Treatment of Pain P.O. Box 70045 Houston, TX 77270 NFTPain@cwo.com http://www.paincare.org Tel: 713-862-9332 Fax: 713-862-9346 |
American Pain Foundation 201 North Charles Street Suite 710 Baltimore, MD 21201-4111 info@painfoundation.org http://www.painfoundation.org Tel: 888-615-PAIN (7246) Fax: 410-385-1832 |
| National Kidney & Urologic Diseases
Information Clearinghouse (NKUDIC) 3 Information Way Bethesda, MD 20892-3580 nkudic@info.niddk.nih.gov http://www.niddk.nih.gov Tel: 301-654-4415 800-891-5390 |
Charcot-Marie-Tooth Association (CMTA) 2700 Chestnut Parkway Chester, PA 19013-4867 info@charcot-marie-tooth.org http://www.charcot-marie-tooth.org Tel: 610-499-9264 800-606-CMTA (2682) Fax: 610-499-9267 |
| Muscular Dystrophy Association 3300 East Sunrise Drive Tucson, AZ 85718-3208 mda@mdausa.org http://www.mda.org Tel: 520-529-2000 800-344-4863 Fax: 520-529-5300 |
American Diabetes Association 1701 North Beauregard Street Alexandria, VA 22311 askada@diabetes.org http://www.diabetes.org Tel: 800-DIABETES (342-2383) 703-549-1500 |
| National Diabetes Information Clearinghouse (NDIC) 1 Information Way Bethesda, MD 20892-3560 ndic@info.niddk.nih.gov http://www.diabetes.niddk.nih.gov Tel: 301-654-3327 800-860-8747 |
- Chronic Pain: Hope Through ResearchChronic pain information page compiled by the National Institute of Neurological Disorders and Stroke (NINDS).
Prepared by:
Office of Communications and Public Liaison
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Bethesda, MD 20892
NINDS health-related material is provided for information purposes only and does not necessarily represent endorsement by or an official position of the National Institute of Neurological Disorders and Stroke or any other Federal agency. Advice on the treatment or care of an individual patient should be obtained through consultation with a physician who has examined that patient or is familiar with that patient's medical history.
All NINDS-prepared information is in the public domain and may be freely copied. Credit to the NINDS or the NIH is appreciated.
Last updated December 11, 2008
National Institute of Neurological Disorders and Stroke
Home | About NINDS | Disorders A - Z | Research Funding | News From NINDS | Find People | Training | Research
Careers@NINDS | FOIA (NIH) | Accessibility Policy | Contact Us | Privacy Statement
